Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-31
1998-07-21
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, A61K 31415
Patent
active
057835942
ABSTRACT:
The invention provides cell modulators comprising certain biologically-active enantiomers of mevalonate and mevalonolactone derivatives. The compounds are broadly clinically useful, particularly in cancer management and treatment of immunological diseases or disorders.
REFERENCES:
patent: 4613610 (1986-09-01), Warung
patent: 4808607 (1989-02-01), Warung
patent: 4933185 (1990-06-01), Brown
patent: 4970221 (1990-11-01), Magnin et al.
Mann, "Membrane Oligosaccharides: Structure and Function during Differentiation", International Review of Cytology 112:67-96 (1988).
Mann Paul L.
Scallen Terence J.
Cook Rebecca
University of New Mexico
LandOfFree
Cell differentiation induction with mevalonate and mevalonolacto does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell differentiation induction with mevalonate and mevalonolacto, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell differentiation induction with mevalonate and mevalonolacto will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1647395